{
    "Symbol": "EW",
    "AssetType": "Common Stock",
    "Name": "Edwards Lifesciences Corp",
    "Description": "Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.",
    "CIK": "1099800",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES",
    "Address": "ONE EDWARDS WAY, IRVINE, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "37264458000",
    "EBITDA": "2028300000",
    "PERatio": "23.95",
    "PEGRatio": "3.068",
    "BookValue": "12.35",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "2.54",
    "RevenuePerShareTTM": "10.27",
    "ProfitMargin": "0.237",
    "OperatingMarginTTM": "0.272",
    "ReturnOnAssetsTTM": "0.123",
    "ReturnOnEquityTTM": "0.22",
    "RevenueTTM": "6204400000",
    "GrossProfitTTM": "4303600000",
    "DilutedEPSTTM": "2.54",
    "QuarterlyEarningsGrowthYOY": "0.206",
    "QuarterlyRevenueGrowthYOY": "0.07",
    "AnalystTargetPrice": "80.71",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "14",
    "AnalystRatingHold": "10",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "2",
    "TrailingPE": "23.95",
    "ForwardPE": "22.68",
    "PriceToSalesRatioTTM": "6.01",
    "PriceToBookRatio": "5.01",
    "EVToRevenue": "5.8",
    "EVToEBITDA": "20.69",
    "Beta": "1.11",
    "52WeekHigh": "96.12",
    "52WeekLow": "58.93",
    "50DayMovingAverage": "85.87",
    "200DayMovingAverage": "81.37",
    "SharesOutstanding": "602400000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}